Featured Research

from universities, journals, and other organizations

A better way of estimating blood loss

Date:
March 6, 2013
Source:
BioMed Central Limited
Summary:
Research suggests that there may be a better way of measuring blood loss due to trauma than the current method, finds a new article. The study shows that base deficit (BD) is a better indicator of hypovolemic shock than the Advanced Trauma Life Support (ATLS) classification, which uses a combination of heart rate, systolic blood pressure and the Glasgow Coma Scale.

Research suggests that there may be a better way of measuring blood loss due to trauma than the current method, finds an article in BioMed Central's open access journal Critical Care. The study shows that base deficit (BD) is a better indicator of hypovolemic shock than the Advanced Trauma Life Support (ATLS) classification, which uses a combination of heart rate, systolic blood pressure and the Glasgow Coma Scale.

Using data from the TraumaRegister DGU® 16,305 patients injured between 2002 and 2010 were classified according to BD and then assessed for demographics, injury characteristics, and transfusion and fluid requirements. Severity of injury, length of stay in ICU or in hospital, morbidity and mortality were all linked to BD. Increase in BD category was associated with worse hypotension, needing more blood, intubation and mechanical breathing.

When validated to the current ATLS classification BD was more accurate at predicting the patients who needed blood products, and the need for massive transfusions. BD was also better at predicting who was at highest risk of death.


Story Source:

The above story is based on materials provided by BioMed Central Limited. Note: Materials may be edited for content and length.


Journal Reference:

  1. Manuel Mutschler, Ulrike Nienaber, Thomas Brockamp, Arasch Wafaisade, Tobias Fabian, Thomas Paffrath, Bertil Bouillon, Marc Maegele, TraumaRegister Dgu. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU. Critical Care, 2013; 17 (2): R42 DOI: 10.1186/cc12555

Cite This Page:

BioMed Central Limited. "A better way of estimating blood loss." ScienceDaily. ScienceDaily, 6 March 2013. <www.sciencedaily.com/releases/2013/03/130305200314.htm>.
BioMed Central Limited. (2013, March 6). A better way of estimating blood loss. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2013/03/130305200314.htm
BioMed Central Limited. "A better way of estimating blood loss." ScienceDaily. www.sciencedaily.com/releases/2013/03/130305200314.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:  

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile iPhone Android Web
    Follow Facebook Twitter Google+
    Subscribe RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins